Loading chat...
FL H1135
Bill
Status
Introduced
2/24/2023
Primary Sponsor
Judiciary Committee
Click for details
AI Summary
- Amends Section 893.03, Florida Statutes, to add nitazene derivatives as a new category (item 63) to Schedule I of Florida's controlled substances list, classifying them as having high abuse potential and no accepted medical use
- Defines controlled nitazene derivatives broadly by their chemical structure: compounds containing a benzimidazole ring with an ethylamine substitution at the 1-position and a benzyl ring substitution at the 2-position, with or without various chemical modifications
- Specifically lists 15 named nitazene compounds including butonitazene, isotonitazene, metonitazene, protonitazene, etonitazene, and others, while using "including, but not limited to" language to capture future analogues
- Exempts substances specifically excepted, listed in another schedule, or contained within FDA-approved pharmaceutical products from the new classification
- Effective date of July 1, 2023
Legislative Description
Nitazene Derivatives
Last Action
Laid on Table; companion bill(s) passed, see SB 736 (Ch. 2023-221)
5/1/2023
Committee Referrals
Judiciary3/21/2023
Justice Appropriations Subcommittee3/13/2023
Criminal Justice Subcommittee3/6/2023
Full Bill Text
No bill text available